SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001837607-24-000015
Filing Date
2024-03-29
Accepted
2024-03-29 15:49:28
Documents
96
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aeon-20231231x10k.htm   iXBRL 10-K 2861197
2 EX-10.11 aeon-20231231xex10d11.htm EX-10.11 106429
3 EX-31_1 aeon-20231231xex31d1.htm EX-31.1 18256
4 EX-31_2 aeon-20231231xex31d2.htm EX-31.2 17565
5 EX-32.1 aeon-20231231xex32d1.htm EX-32.1 8816
6 EX-32.2 aeon-20231231xex32d2.htm EX-32.2 9194
7 EX-97 aeon-20231231xex97.htm EX-97 36183
8 GRAPHIC aeon-20231231x10k006.jpg GRAPHIC 76091
  Complete submission text file 0001837607-24-000015.txt   12845834

Data Files

Seq Description Document Type Size
9 EX-101.SCH aeon-20231231.xsd EX-101.SCH 104053
10 EX-101.CAL aeon-20231231_cal.xml EX-101.CAL 57820
11 EX-101.DEF aeon-20231231_def.xml EX-101.DEF 486574
12 EX-101.LAB aeon-20231231_lab.xml EX-101.LAB 779531
13 EX-101.PRE aeon-20231231_pre.xml EX-101.PRE 661123
100 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20231231x10k_htm.xml XML 2084107
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40021 | Film No.: 24804012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)